✦ LIBER ✦

5075 POSTER Non-pegylated Liposomal Doxorubicin (Myocet e) Plus Docetaxel (Taxotere e) (MYTAX), as First-line Chemotherapy (CHT), in Metastatic Breast Cancer (MBC): Results of a Phase II Study

✍ Scribed by Imperatori, L.; Lippe, P.; Trapuzzano, C.; Laid, G.; Cappelletti, C.; Tamburrano, T.; Mattioli, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Myotax: A phase II trial of docetaxel pl

✍ E. Curtit; P. Nouyrigat; N. Dohollou; E. Levy; A. Lortholary; J. Gligorov; T. Fa 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 356 KB

A multicentre Phase II study of non-pegy

✍ M. Venturini; C. Bighin; F. Puglisi; N. Olmeo; E. Aitini; G. Colucci; O. Garrone 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Interim safety analysis of a randomized

✍ S. Al-Batran; S. Saupe; A. Kerber; H.J. Lueck; C. Jackisch; M. Untch; M. Schmidt 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Non-pegylated liposomal doxorubicin comb

✍ S. Del Barco; R. Colomer; L. Calvo; I. Tusquets; E. Adrover; P. Sánchez; J. Rifà 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 220 KB

A randomized phase III study comparing p

✍ Smorenburg, C. H.; de Groot, S. M.; van Leeuwen-Stok, A. E.; Hamaker, M. E.; Wym 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 218 KB

413 POSTER A multicenter phase II study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB